BAFNA PHARMACEUTICALS
Back to Balance Sheet
|
BAFNA PHARMACEUTICALS Last 5 Year Total Debt History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹28 Cr | ₹24 Cr | ₹23 Cr | ₹11 Cr | ₹13 Cr |
What is the latest Total Debt ratio of BAFNA PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹24 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹13 Cr |
How is Total Debt of BAFNA PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹28 Cr | 15.62 | |
| Mar2024 | ₹24 Cr | 6.39 | |
| Mar2023 | ₹23 Cr | 107.27 | |
| Mar2022 | ₹11 Cr | -14.92 | |
| Mar2021 | ₹13 Cr | - | |
Compare Total Debt of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹647.5 Cr | -1.5% | 31.7% | 231.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,271.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,843.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,000.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,072.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,073.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -1.5% |
31.7% |
231.2% |
| SENSEX | -0.8% |
0.5% |
-3.8% |
You may also like the below Video Courses